We round up the latest news in agetech research and innovation, from a human trial in ‘reverse ageing’ to the launch of a domestic longevity pod....
A new AI tool flags early Alzheimer’s, identifying about four in five people who would otherwise be missed by clinicians. Trained on UCLA Health patient records...
Gap is partnering with Spear Bio on Bio-Hermes-002, an Alzheimer’s study comparing blood and digital biomarkers across cognitive conditions. The observational platform study compares blood-based and...
Insilico Medicine has agreed a US$66m deal with a Chinese biotech for half of the rights to a brain-penetrant Parkinson’s drug. Under the agreement, the artificial...
Scientists have developed a nanoparticle strategy to broaden which disease-causing proteins medicines can target, giving options for dementia and brain cancer. A perspective outlines an approach...
Exciva has raised US$59.4m in series B funding to support a phase 2 trial of its Alzheimer’s therapy. The clinical-stage biopharmaceutical company is developing treatments for...
L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as medicine. The round brings its series...
